发明申请
US20050142192A1 Oral administration of [2-(8,9-dioxo-2,6-diazabicyclo[5.2.0]non-1(7)-en-2-yl)alkyl] phosphonic acid and derivatives
审中-公开
口服给予[2-（8,9-二氧代-2,6-二氮杂双环[5.2.0]壬-1（7） - 烯-2-基）烷基]膦酸及其衍生物
![Oral administration of [2-(8,9-dioxo-2,6-diazabicyclo[5.2.0]non-1(7)-en-2-yl)alkyl] phosphonic acid and derivatives](/docs/US/2005-06-30/US20050142192A1/abs.jpg.600x600.jpg)
- 专利标题： Oral administration of [2-(8,9-dioxo-2,6-diazabicyclo[5.2.0]non-1(7)-en-2-yl)alkyl] phosphonic acid and derivatives
- 专利标题（中）： 口服给予[2-（8,9-二氧代-2,6-二氮杂双环[5.2.0]壬-1（7） - 烯-2-基）烷基]膦酸及其衍生物
-
申请号： US10961871申请日： 2004-10-08
-
公开(公告)号： US20050142192A1公开(公告)日： 2005-06-30
- 发明人: Eric Benjamin , William Cloud , Muhammad Ashraf , Mohammed Islam , Michael Brandt , Gerald Tremblay
- 申请人： Eric Benjamin , William Cloud , Muhammad Ashraf , Mohammed Islam , Michael Brandt , Gerald Tremblay
- 申请人地址： US NJ Madison
- 专利权人： Wyeth
- 当前专利权人： Wyeth
- 当前专利权人地址： US NJ Madison
- 主分类号： A61K31/55
- IPC分类号： A61K31/55 ; A61K31/675 ; A61K9/20
![Oral administration of [2-(8,9-dioxo-2,6-diazabicyclo[5.2.0]non-1(7)-en-2-yl)alkyl] phosphonic acid and derivatives](/abs-image/US/2005/06/30/US20050142192A1/abs.jpg.150x150.jpg)
摘要：
Solid, pharmaceutical dosage forms of [2-(8,9-dioxo-2,6-diazabicyclo [5.2.0]non-1(7)-en-2-yl)alkyl]phosphonic acid and derivatives thereof are disclosed. In addition, methods of use are disclosed for the treatment, inter alia, of cerebral vascular disorders, anxiety disorders; mood disorders; schizophrenia; schizophreniform disorder; schizoaffective disorder; cognitive impairment; chronic neurodegenerative disorders; inflammatory diseases; fibromyalgia; complications from herpes zoster; prevention of tolerance to opiate analgesia; withdrawal symptoms from addictive drugs; and pain.
信息查询
